HowardJ.M., ChremosA.N., CollenM.J.Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: Comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome.Gastroenterology1985; 88: 1026–33.
7.
NortonJ.A., CollenM.J., GardnerJ.D.Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome.Ann Surg1986; 204: 468–78.
8.
HowardT.J., ZinnerM.J., StabileB.E., PassaroE.Gastrinoma excision for cure.Ann Surg1989; 211: 9–14.
9.
NortonJ.A., FrakerD.L., AlexanderH.R.Surgery increases survival in patients with gastrinoma.Ann Surg2006; 244: 410–9.
10.
JordonP.H.A personal experience with pancreatic and duodenal neuroendocrine tumors.J Am Coll Surg1999; 189: 470–82.
11.
StabileB.E., PassaroE.Benign and malignant gastrinoma.Am J Surg1985; 149: 144–50.
12.
MeeA.S., BornmanP.C., MarksI.N.Conservative surgery in the Zollinger-Ellison syndrome.Br J Surg1984; 71: 423–4.
13.
BornmanP.C., MarksI.N., MeeA.S., PriceS.Conservative surgery for extra-pancreatic gastrinoma with lymph node metastases.Br J Surg1987; 74: 198–201.
14.
FriesenS.Are ‘aberrant nodal gastrinomas’ pathogenetically similar to ‘lateral aberrant thyroid’ nodules?Surgery1990; 107: 236–8.
15.
RichardsonC.T., FeldmanM., McClellandR.N.Effect of vagotomy in Zollinger-Ellison syndrome.Gastroenterology1979; 77: 682–6.
16.
VogelS.B., WolfeM.M., McGuiganJ.I.Localization and resection of gastrinomas in Zollinger-Ellison syndrome.Ann Surg1987; 550–6.
17.
WilsonS.D.The role of surgery in children with the Zollinger-Ellison syndrome.Surgery1982; 92: 682–92.
ThompsonJ.C., LewisB.G., WeinerI., TownsendC.M.The role of surgery in the Zollinger-Ellison Syndrome.1983; 197(5): 594–605.
21.
DelcoreR., CheungL.Y., FriesenS.R.Outcome of lymph node involvement in patients with the Zollinger-Ellison syndrome.Ann Surg1988; 208: 291–6.
22.
NortonJ.A., AlexanderH.R., FrakerD.L.Possible primary lymph node gastrinoma: Occurrence, natural history, and predictive factors; A prospective study.Ann Surg2003; 227: 650–9.
23.
HerrmannM.R., CieslaM., ChejfecG.Primary nodal gastrinomas: An immunohistochemical study in support of a theory.Arch Pathol Lab Med2000; 124: 832–5.
24.
PerrierN.D., BattsK.P., ThompsonG.B.An immunohistochemical survey for neuroendocrine cells in regional pancreatic lymph nodes: A plausible explanation for primary nodal gastrinomas?Surgery1995; 118: 957–66.
25.
NortonJ.A., KilenM., LiM.Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.Arch Surg2003; 138: 859–66.
26.
SarmientoJ.M., FarnellM.B., QueF.F.G., NagorneyD.M.Pancreaticoduodenectomy for islet cell tumors of the head of the pancreas: Long term survival analysis.World J Surg2002; 26: 1267–71.
